COVID-19 Updates
From the Journals
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...
From the Journals
Study suggests no added risk of blood clots in COVID-19 outpatients
From the Journals
Excess deaths jump 23% in U.S. in 2020, mostly because of COVID-19
From the Journals
AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?
The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.
News from the FDA/CDC
COVID-19 in 2020: Deaths and disparities
Feature
Mishap ruins millions of J&J COVID vaccine doses
News
CDC adds new medical conditions to COVID-19 high-risk list
...
Feature
Vaccine mismatch: What to do after dose 1 when plans change
Latest News
COVID vaccines could lose their punch within a year, experts say
Almost a third said ineffectiveness would happen in 9 months or less; 18.2% said 6 months or less.
Conference Coverage
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
The rationale is to optimize the antibody response to the killed-adenovirus COVID-19 vaccine.
Feature
Long-haul COVID-19 brings welcome attention to POTS
Postural orthostatic tachycardia syndrome (POTS) is one manifestation of so-called long-haul COVID-19. Patients may benefit from research funding...